{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:29:07Z","timestamp":1792225747312,"version":"4.4.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>Cachexia is a syndrome of unintentional body weight loss and muscle wasting occurring in 30% of all cancer patients. Patients with cancers most commonly leading to brain metastases have a risk for cachexia development between 20 and 80%. Cachexia causes severe weakness and fatigue and negatively impacts quality and length of life. The negative energy balance in cachectic patients is most often caused by a combination of increased energy expenditure and decreased energy intake. Basal metabolic rate may be elevated due to tumor secreted factors and a systemic inflammatory response leading to inefficiency in energy production pathways and increased energy demand by the tumor and host tissues. A growing body of research explores physiological and molecular mechanisms of metabolic dysregulation in cachexia. However, decreased energy intake and physical functioning also remain important contributors to cachexia pathogenesis. Pain associated with metastatic malignancy is significantly associated with inflammation, thus making inflammation a common link between cancer pain and cachexia. Pain may also influence appetite and food intake and exacerbate fatigue and functional decline, potentially contributing to cachexia severity. Cancer pain and cachexia often occur simultaneously; however, causal relationships remain to be established. Appropriate assessment and treatment of pain in advanced cancer patients may positively impact nutrition status and physical functioning, slowing the progression of cachexia and improving quality and length of life for patients.<\/jats:p>","DOI":"10.3389\/fpain.2022.971295","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T02:46:52Z","timestamp":1661136412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Cancer cachexia: Pathophysiology and association with cancer-related pain"],"prefix":"10.3389","volume":"3","author":[{"given":"Michelle L.","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcsm.12402","article-title":"Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review","volume":"10","author":"Anker","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","article-title":"Brain metastases: epidemiology","volume":"149","author":"Ostrom","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/cam4.621","article-title":"Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens","volume":"5","author":"Ali","year":"2016","journal-title":"Cancer Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/0003489414523564","article-title":"Effect of weight loss on short-term outcomes and costs of care after head and neck cancer surgery","volume":"123","author":"Gourin","year":"2014","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/13696998.2016.1181640","article-title":"Cachexia among US cancer patients","volume":"19","author":"Arthur","year":"2016","journal-title":"J Med Econ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1634\/theoncologist.2010-0019","article-title":"More is better: a multimodality approach to cancer cachexia","volume":"15","author":"del","year":"2010","journal-title":"Oncologist"},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia","volume":"14","author":"Mantovani","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21037\/apm.2018.08.05","article-title":"Combination therapy in cachexia","volume":"8","author":"del","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br J Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6604828","article-title":"The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer","volume":"100","author":"Deans","year":"2009","journal-title":"Br J Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","article-title":"Emerging signaling mediators in the anorexia\u2013cachexia syndrome of cancer","volume":"8","author":"Talbert","year":"2022","journal-title":"Trends in Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clnu.2009.07.001","article-title":"Resting energy expenditure and body composition in patients with newly detected cancer","volume":"29","author":"Cao","year":"2010","journal-title":"Clin Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0277-5379(91)90050-N","article-title":"Elevated energy expenditure in cancer patients with solid tumours","volume":"27","author":"Hyltander","year":"1991","journal-title":"Eur J Cancer Clin Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3945\/ajcn.2010.29885","article-title":"Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure","volume":"92","author":"Wang","year":"2010","journal-title":"Am J Clin Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10549-016-3938-1","article-title":"Resting heart rate as a prognostic factor for mortality in patients with breast cancer","volume":"159","author":"Lee","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/ejhf.670","article-title":"Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study","volume":"18","author":"Anker","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"B25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1365-2362.1993.tb00716.x","article-title":"Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours","volume":"23","author":"Hyltander","year":"1993","journal-title":"Eur J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0959-8049(99)00273-7","article-title":"\u03b2-Adrenoceptor activity and resting energy metabolism in weight losing cancer patients","volume":"36","author":"Hyltander","year":"2000","journal-title":"Eur J Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF00402783","article-title":"Brown adipose tissue in cancer patients: possible cause of cancer-induced cachexia","volume":"111","author":"Shellock","year":"1986","journal-title":"J Cancer Res Clin Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4161\/15384047.2014.987075","article-title":"Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice","volume":"16","author":"Kliewer","year":"2015","journal-title":"Cancer Biol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12976-015-0015-0","article-title":"Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia","volume":"12","author":"Friesen","year":"2015","journal-title":"Theor Biol Med Model."},{"key":"B33","doi-asserted-by":"publisher","first-page":"831934","DOI":"10.3389\/fnut.2022.831934","article-title":"Managing nutrition impact symptoms in cancer cachexia: a case series and mini review","volume":"9","author":"Khorasanchi","year":"2022","journal-title":"Front Nutr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13539-012-0099-x","article-title":"Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case-control study","volume":"4","author":"Omlin","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0241305","DOI":"10.1371\/journal.pone.0241305","article-title":"Malnutrition and nutrition impact symptoms (NIS) in surgical patients with cancer","volume":"15","author":"Viana","year":"2020","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpainsymman.2012.06.020","article-title":"Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis","volume":"46","author":"Oberholzer","year":"2013","journal-title":"J Pain Symptom Manage."},{"key":"B37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1074\/jbc.M207129200","article-title":"Tumor necrosis factor-regulated biphasic activation of NF-\u03bab is required for cytokine-induced loss of skeletal muscle gene products","volume":"278","author":"Ladner","year":"2003","journal-title":"J Biol Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J Clin Investig."},{"key":"B40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int J Cancer."},{"key":"B41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/1097-0142(19910115)67:2<486::aid-cncr2820670228>3.0.co;2-1","article-title":"Insulin secretion and action in patients with pancreatic cancer","volume":"67","author":"Cersosimo","year":"1991","journal-title":"Cancer."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2567150","DOI":"10.1155\/2022\/2567150","article-title":"Curcumin targeting NF- \u03ba B\/ubiquitin-proteasome-system axis ameliorates muscle atrophy in triple-negative breast cancer cachexia mice","volume":"2022","author":"Zhang","year":"2022","journal-title":"Mediators Inflamm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B44","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/jcsm.12854","article-title":"Activation of Akt\u2013mTORC1 signalling reverts cancer-dependent muscle wasting","volume":"13","author":"Geremia","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B45","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/bjc.1993.126","article-title":"Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia","volume":"67","author":"Smith","year":"1993","journal-title":"Br J Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","article-title":"Autophagy pathway: cellular and molecular mechanisms","volume":"14","author":"Yu","year":"2018","journal-title":"Autophagy."},{"key":"B47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","article-title":"Autophagy in metabolic disease and ageing","volume":"17","author":"Kitada","year":"2021","journal-title":"Nat Rev Endocrinol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol Cell."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain."},{"key":"B52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat Rev Cancer."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1016\/j.ejca.2010.04.017","article-title":"An international multicentre validation study of a pain classification system for cancer patients","volume":"46","author":"Fainsinger","year":"2010","journal-title":"Eur J Cancer."},{"key":"B54","doi-asserted-by":"publisher","first-page":"984570","DOI":"10.1155\/2015\/984570","article-title":"Treatment of cancer pain by targeting cytokines","volume":"2015","author":"Vendrell","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B55","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrc2507","article-title":"Cytokines and their relationship to the symptoms and outcome of cancer","volume":"8","author":"Seruga","year":"2008","journal-title":"Nat Rev Cancer."},{"key":"B56","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.pain.2010.10.035","article-title":"Cancer pain and its relationship to systemic inflammation: an exploratory study","volume":"152","author":"Laird","year":"2011","journal-title":"Pain."},{"key":"B57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/pmr.2021.0004","article-title":"C-reactive protein and its relationship with pain in patients with advanced cancer cachexia: secondary cross-sectional analysis of a multicenter prospective cohort study","volume":"2","author":"Amano","year":"2021","journal-title":"Palliat Med Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00228-018-2527-0","article-title":"Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients","volume":"74","author":"Tanaka","year":"2018","journal-title":"Eur J Clin Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1049909120945570","article-title":"Relationship between tramadol response and cancer cachexia: a retrospective cohort study","volume":"38","author":"Morio","year":"2021","journal-title":"Am J Hosp Palliat Care."},{"key":"B60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jpainsymman.2016.12.325","article-title":"Differences in symptom burden among cancer patients with different stages of cachexia","volume":"53","author":"Zhou","year":"2017","journal-title":"J Pain Symptom Manage."},{"key":"B61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jcsm.12499","article-title":"The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer","volume":"11","author":"Daly","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00520-012-1483-y","article-title":"Validation of the head and neck patient symptom checklist as a nutrition impact symptom assessment tool for head and neck cancer patients","volume":"21","author":"Schmidt","year":"2013","journal-title":"Support Care Cancer."},{"key":"B63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00520-012-1514-8","article-title":"Symptoms in advanced pancreatic cancer are of importance for energy intake","volume":"21","author":"Bye","year":"2013","journal-title":"Support Care Cancer."},{"key":"B64","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/hed.23023","article-title":"Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view","volume":"35","author":"Kubrak","year":"2013","journal-title":"Head Neck."},{"key":"B65","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1158\/1078-0432.CCR-07-1147","article-title":"Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia","volume":"13","author":"Fouladiun","year":"2007","journal-title":"Clin Cancer Res."},{"key":"B66","first-page":"283","article-title":"The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia","volume":"6","author":"Robinson","year":"2008","journal-title":"J Support Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpainsymman.2010.10.261","article-title":"Pain, depression, and fatigue as a symptom cluster in advanced cancer","volume":"42","author":"Laird","year":"2011","journal-title":"J Pain Symptom Manage."},{"key":"B68","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jpainsymman.2011.03.025","article-title":"Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set","volume":"43","author":"Minton","year":"2012","journal-title":"J Pain Symptom Manage."},{"key":"B69","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13539-010-0016-0","article-title":"Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer","volume":"1","author":"Kilgour","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B70","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/jcsm.12562","article-title":"The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer","volume":"11","author":"Derksen","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1016\/j.jpainsymman.2021.02.034","article-title":"Quality of life and symptom burden improve in patients attending a multidisciplinary clinical service for cancer cachexia: a retrospective observational review","volume":"62","author":"Bland","year":"2021","journal-title":"J Pain Symptom Manage."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of cancer cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J Clin Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/jcsm.12799","article-title":"Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia","volume":"12","author":"Gresham","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B74","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00726-020-02822-7","article-title":"Oral nutritional supplement prevents weight loss and reduces side effects in patients in advanced lung cancer chemotherapy","volume":"52","author":"Torricelli","year":"2020","journal-title":"Amino Acids."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00520-018-4154-9","article-title":"del Roc\u00edo Guillen N\u00fa\u00f1ez M, Flores-Estrada D, O\u00f1ate-Oca\u00f1a LF, Zatarain-Barr\u00f3n ZL, Barr\u00f3n F, Arrieta O. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial","volume":"26","author":"Turcott","year":"2018","journal-title":"Support Care Cancer."}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.971295\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T02:46:56Z","timestamp":1661136416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.971295\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":75,"alternative-id":["10.3389\/fpain.2022.971295"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2022.971295","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"971295"}}